KYMR
Price
$29.07
Change
+$0.50 (+1.75%)
Updated
May 7, 04:59 PM (EDT)
Capitalization
1.86B
2 days until earnings call
RLAY
Price
$2.94
Change
-$0.21 (-6.67%)
Updated
May 7, 04:59 PM (EDT)
Capitalization
540.05M
97 days until earnings call
Ad is loading...

KYMR vs RLAY

Header iconKYMR vs RLAY Comparison
Open Charts KYMR vs RLAYBanner chart's image
Kymera Therapeutics
Price$29.07
Change+$0.50 (+1.75%)
Volume$15.82K
Capitalization1.86B
Relay Therapeutics
Price$2.94
Change-$0.21 (-6.67%)
Volume$108.9K
Capitalization540.05M
KYMR vs RLAY Comparison Chart
Loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
KYMR vs. RLAY commentary
May 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and RLAY is a Hold.

Ad is loading...
COMPARISON
Comparison
May 08, 2025
Stock price -- (KYMR: $28.57 vs. RLAY: $3.15)
Brand notoriety: KYMR and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 178% vs. RLAY: 203%
Market capitalization -- KYMR: $1.86B vs. RLAY: $540.05M
KYMR [@Biotechnology] is valued at $1.86B. RLAY’s [@Biotechnology] market capitalization is $540.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $309.18B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 3 TA indicator(s) are bullish while RLAY’s TA Score has 8 bullish TA indicator(s).

  • KYMR’s TA Score: 3 bullish, 7 bearish.
  • RLAY’s TA Score: 8 bullish, 2 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а -15.20% price change this week, while RLAY (@Biotechnology) price change was +1.61% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.53%. For the same industry, the average monthly price growth was +10.36%, and the average quarterly price growth was -14.13%.

Reported Earning Dates

KYMR is expected to report earnings on Aug 01, 2025.

RLAY is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-4.53% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KYMR($1.86B) has a higher market cap than RLAY($540M). RLAY YTD gains are higher at: -23.544 vs. KYMR (-28.983). KYMR has higher annual earnings (EBITDA): -216.24M vs. RLAY (-380.21M). RLAY has more cash in the bank: 781M vs. KYMR (489M). RLAY has less debt than KYMR: RLAY (48.5M) vs KYMR (87.8M). KYMR has higher revenues than RLAY: KYMR (47.1M) vs RLAY (10M).
KYMRRLAYKYMR / RLAY
Capitalization1.86B540M344%
EBITDA-216.24M-380.21M57%
Gain YTD-28.983-23.544123%
P/E RatioN/AN/A-
Revenue47.1M10M471%
Total Cash489M781M63%
Total Debt87.8M48.5M181%
TECHNICAL ANALYSIS
Technical Analysis
KYMRRLAY
RSI
ODDS (%)
Bearish Trend 2 days ago
78%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
72%
MACD
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
74%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
70%
View a ticker or compare two or three
Ad is loading...
KYMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RLAY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMBPX43.95N/A
N/A
Principal MidCap R5
NBHAX14.05N/A
N/A
Neuberger Berman Equity Income A
PSCZX22.56N/A
N/A
PGIM Jennison Small Company Z
DINIX21.68N/A
N/A
BNY Mellon International Stock Index I
FOBAX19.40-0.06
-0.31%
Tributary Balanced Instl

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with CCCC. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then CCCC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
-14.92%
CCCC - KYMR
63%
Loosely correlated
-12.96%
NRIX - KYMR
56%
Loosely correlated
-11.84%
RVMD - KYMR
56%
Loosely correlated
-5.92%
IMNM - KYMR
55%
Loosely correlated
-10.29%
XENE - KYMR
55%
Loosely correlated
-6.29%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with BCYC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then BCYC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-5.12%
BCYC - RLAY
48%
Loosely correlated
-18.32%
XNCR - RLAY
48%
Loosely correlated
-21.08%
BDTX - RLAY
46%
Loosely correlated
-12.28%
RVMD - RLAY
45%
Loosely correlated
-5.92%
KYMR - RLAY
45%
Loosely correlated
-14.92%
More